Drug
Icp B381
Icp B381: highest development phase Phase 1/2, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-B381 NCT07901413 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Icp B381 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.